Prediction of Drug-induced Liver Injury Using Keratinocytes

Overview

Journal J Appl Toxicol

Specialty Toxicology

Date 2017 Feb 1

PMID 28138970

Citations 4

Authors

Rika Hirashima

Tomoo Itoh

Robert H Tukey

Ryoichi Fujiwara

Affiliations

Soon will be listed here.

Abstract

Drug-induced liver injury (DILI) is one of the most common adverse drug reactions. DILI is often accompanied by skin reactions, including rash and pruritus. However, it is still unknown whether DILI-associated genes such as S100 calcium-binding protein A and interleukin (IL)-1β are involved in drug-induced skin toxicity. In the present study, most of the tested hepatotoxic drugs such as pioglitazone and diclofenac induced DILI-associated genes in human and mouse keratinocytes. Keratinocytes of mice at higher risk for DILI exhibited an increased IL-1β basal expression. They also showed a higher inducibility of IL-1β when treated by pioglitazone. Mice at higher risk for DILI showed even higher sums of DILI-associated gene basal expression levels and induction rates in keratinocytes. Our data suggest that DILI-associated genes might be involved in the onset and progression of drug-induced skin toxicity. Furthermore, we might be able to identify individuals at higher risk of developing DILI less invasively by examining gene expression patterns in keratinocytes. Copyright © 2017 John Wiley & Sons, Ltd.

Citing Articles

HLA-B*57:01-dependent intracellular stress in keratinocytes triggers dermal hypersensitivity reactions to abacavir.

Kazaoka A, Fujimori S, Yamada Y, Shirayanagi T, Gao Y, Kuwahara S PNAS Nexus. 2024; 3(4):pgae140.

PMID: 38628599 PMC: 11018537. DOI: 10.1093/pnasnexus/pgae140.

Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction.

Segovia-Zafra A, Di Zeo-Sanchez D, Lopez-Gomez C, Perez-Valdes Z, Garcia-Fuentes E, Andrade R Acta Pharm Sin B. 2022; 11(12):3685-3726.

PMID: 35024301 PMC: 8727925. DOI: 10.1016/j.apsb.2021.11.013.

Critical Review of Gaps in the Diagnosis and Management of Drug-Induced Liver Injury Associated with Severe Cutaneous Adverse Reactions.

Villanueva-Paz M, Niu H, Segovia-Zafra A, Medina-Caliz I, Sanabria-Cabrera J, Lucena M J Clin Med. 2021; 10(22).

PMID: 34830594 PMC: 8618381. DOI: 10.3390/jcm10225317.

Composite ammonium glycyrrhizin has hepatoprotective effects in chicken hepatocytes with lipopolysaccharide/enrofloxacin-induced injury.

Guo X, Li W, An R, Huang M, Yu Z Exp Ther Med. 2020; 20(5):52.

PMID: 32952642 PMC: 7485299. DOI: 10.3892/etm.2020.9180.

References

May L, Lefkowitch J, Kram M, Rubin D . Mixed hepatocellular-cholestatic liver injury after pioglitazone therapy. Ann Intern Med. 2002; 136(6):449-52. DOI: 10.7326/0003-4819-136-6-200203190-00008. View

Chase M, Yarze J . Pioglitazone-associated fulminant hepatic failure. Am J Gastroenterol. 2002; 97(2):502-3. DOI: 10.1111/j.1572-0241.2002.05516.x. View

Yun J, Kim C, Bae I, Park Y, Chung J, Lim K . Determination of the key innate genes related to individual variation in carbon tetrachloride-induced hepatotoxicity using a pre-biopsy procedure. Toxicol Appl Pharmacol. 2009; 239(1):55-63. DOI: 10.1016/j.taap.2009.05.018. View

OBrien P, Irwin W, Diaz D, Howard-Cofield E, Krejsa C, Slaughter M . High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening. Arch Toxicol. 2006; 80(9):580-604. DOI: 10.1007/s00204-006-0091-3. View

Choi B, Oh G, Lee J, Mok J, Kim D, Jeong S . Prenylated chalcone from Sophora flavescens suppresses Th2 chemokine expression induced by cytokines via heme oxygenase-1 in human keratinocytes. Arch Pharm Res. 2010; 33(5):753-60. DOI: 10.1007/s12272-010-0515-8. View

Barker B, Taxman D, Ting J . Cross-regulation between the IL-1β/IL-18 processing inflammasome and other inflammatory cytokines. Curr Opin Immunol. 2011; 23(5):591-7. PMC: 3380339. DOI: 10.1016/j.coi.2011.07.005. View

Hayashi P, Fontana R, Chalasani N, Stolz A, Talwalkar J, Navarro V . Under-reporting and Poor Adherence to Monitoring Guidelines for Severe Cases of Isoniazid Hepatotoxicity. Clin Gastroenterol Hepatol. 2015; 13(9):1676-82.e1. PMC: 4653068. DOI: 10.1016/j.cgh.2015.02.024. View

Usui T, Mise M, Hashizume T, Yabuki M, Komuro S . Evaluation of the potential for drug-induced liver injury based on in vitro covalent binding to human liver proteins. Drug Metab Dispos. 2009; 37(12):2383-92. DOI: 10.1124/dmd.109.028860. View

Ehrchen J, Sunderkotter C, Foell D, Vogl T, Roth J . The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol. 2009; 86(3):557-66. DOI: 10.1189/jlb.1008647. View

10.

Pinto A, Cummings O, Chalasani N . Severe but reversible cholestatic liver injury after pioglitazone therapy. Ann Intern Med. 2002; 137(10):857. DOI: 10.7326/0003-4819-137-10-200211190-00023. View

11.

Robles-Diaz M, Lucena M, Kaplowitz N, Stephens C, Medina-Caliz I, Gonzalez-Jimenez A . Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury. Gastroenterology. 2014; 147(1):109-118.e5. DOI: 10.1053/j.gastro.2014.03.050. View

12.

Floyd J, Barbehenn E, Lurie P, Wolfe S . Case series of liver failure associated with rosiglitazone and pioglitazone. Pharmacoepidemiol Drug Saf. 2009; 18(12):1238-43. DOI: 10.1002/pds.1804. View

13.

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

14.

Fujiwara R, Chen S, Karin M, Tukey R . Reduced expression of UGT1A1 in intestines of humanized UGT1 mice via inactivation of NF-κB leads to hyperbilirubinemia. Gastroenterology. 2011; 142(1):109-118.e2. PMC: 3428231. DOI: 10.1053/j.gastro.2011.09.045. View

15.

Rzany B, Correia O, Kelly J, Naldi L, Auquier A, Stern R . Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions. Lancet. 1999; 353(9171):2190-4. DOI: 10.1016/s0140-6736(98)05418-x. View

16.

Holt M, Ju C . Mechanisms of drug-induced liver injury. AAPS J. 2006; 8(1):E48-54. PMC: 2751423. DOI: 10.1208/aapsj080106. View

17.

Shaw P, Hopfensperger M, Ganey P, Roth R . Lipopolysaccharide and trovafloxacin coexposure in mice causes idiosyncrasy-like liver injury dependent on tumor necrosis factor-alpha. Toxicol Sci. 2007; 100(1):259-66. DOI: 10.1093/toxsci/kfm218. View

18.

Barbaud A, Collet E, Milpied B, Assier H, Staumont D, Avenel-Audran M . A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions. Br J Dermatol. 2012; 168(3):555-62. DOI: 10.1111/bjd.12125. View

19.

Mitsugi R, Sumida K, Fujie Y, Tukey R, Itoh T, Fujiwara R . Acyl-glucuronide as a Possible Cause of Trovafloxacin-Induced Liver Toxicity: Induction of Chemokine (C-X-C Motif) Ligand 2 by Trovafloxacin Acyl-glucuronide. Biol Pharm Bull. 2016; 39(10):1604-1610. PMC: 5673480. DOI: 10.1248/bpb.b16-00195. View

20.

Lotze M, Tracey K . High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol. 2005; 5(4):331-42. DOI: 10.1038/nri1594. View